FINWIRES · TerminalLIVE
FINWIRES

Update: Steven Madden Shares Rise After Q2 Beat

By

(Updates to add the company's latest stock move in the headline and in the first paragraph.)

Steven Madden (SHOO) shares were up over 7% in Thursday trading after the company reported better-than-expected Q2 results and raised its fiscal 2026 outlook.

The company posted quarterly adjusted net income of $0.44 per diluted share, up from $0.20 a year earlier.

Analysts polled by FactSet expected $0.32.

Revenue for the quarter ended June 30 was $665.9 million, up from $559 million a year earlier.

Analysts expected revenue of $635.4 million.

The company raised its fiscal 2026 adjusted diluted EPS to a range of $2.05 to $2.15, up from its previous guidance range of $2.00 to $2.10. Analysts surveyed by FactSet expect $2.14.

Steven Madden now expects fiscal 2026 revenue to increase 11% to 13%, up from its previous guidance of 10% to 12%.

Price: $46.48, Change: $+3.08, Percent Change: +7.09%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT